RecruitingPhase 1NCT07454642
AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors
Sponsor: Avacta Life Sciences Ltd
Scottsdale, AZ · +6 more sites
Breast Cancer clinical trials in Scottsdale, AZ
12 recruiting breast cancer studies with a site in Scottsdale, AZ.
RecruitingPhase 2NCT05557877
Low Dose Aspirin for the Prevention of Postpartum Related Breast Cancer
Sponsor: Mayo Clinic
Scottsdale, AZ · +4 more sites
RecruitingNot applicableNCT07214532
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
Sponsor: Natera, Inc.
Phoenix, AZ · Scottsdale, AZ · Tucson, AZ · +46 more sites
RecruitingPhase 3NCT06492616
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Sponsor: Stemline Therapeutics, Inc.
Chandler, AZ · Gilbert, AZ · Phoenix, AZ · +173 more sites
RecruitingPhase 2NCT06525766
Adaptive Therapy With Capecitabine for Treatment of Metastatic ER Positive, HER2 Negative Breast Cancer
Sponsor: Mayo Clinic
Scottsdale, AZ
RecruitingPhase 3NCT05696626
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
Sponsor: LeonaBio
Scottsdale, AZ · Tucson, AZ · +34 more sites
RecruitingPhase not listedNCT03448926
The PREDICT Registry:
Sponsor: PreludeDx
Scottsdale, AZ · +29 more sites
RecruitingPhase 4NCT04373564
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
Sponsor: Guerbet
Scottsdale, AZ · +15 more sites
RecruitingPhase 1 / Phase 2NCT06249048
Phase 1/2 Study of Intratumoral Injection of STX-001 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab
Sponsor: Strand Therapeutics Inc.
Scottsdale, AZ · +5 more sites
RecruitingPhase 1 / Phase 2NCT05824975
A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
Sponsor: GI Innovation, Inc.
Scottsdale, AZ · +4 more sites
RecruitingPhase 1 / Phase 2NCT04787042
Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
Sponsor: Simcha IL-18, Inc.
Scottsdale, AZ · +5 more sites
RecruitingPhase 1NCT04282044
Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies
Sponsor: BioEclipse Therapeutics
Scottsdale, AZ · +2 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.